HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Rad (Q42014057)
Jump to navigation
Jump to search
scientific article published on 29 November 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Rad |
scientific article published on 29 November 2016 |
Statements
HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG) (English)
Claus Belka
Jürgen Debus
Stephanie E Combs
Annett Linge
Steffen Löck
Alexander Nowak
Volker Gudziol
Chiara Valentini
Martin Jütz
Inge Tinhofer
Volker Budach
Ali Sak
Martin Stuschke
Anca-Ligia Grosu
Amir Abdollahi
Steffi Pigorsch
David Mönnich
Daniela E Aust
Gustavo B Baretton
Jens Overgaard
DKTK-ROG
29 November 2016